AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
AbbVie has long been under pressure to diversify its portfolio and its shares have lost more than a third of their value since…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.